Meeting
2017 ASCO Quality Care Symposium
Uptake and effectiveness of FOLFIRINOX for advanced pancreas cancer: A population-based study.
Authors
Safiya Karim
Cancer Care and Epidemiology, Queen's University, Kingston, ON, Canada
Safiya Karim, Jina Zhang-Salomons, James Joseph Biagi, Tim Asmis, Christopher M. Booth
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Patient Safety and Science of Quality
Track
Patient Safety,Science of Quality
Sub Track
Studies Using Registries or Combining Large Databases
Citation
J Clin Oncol 35, 2017 (suppl 8S; abstract 245)
DOI
10.1200/JCO.2017.35.8_suppl.245
Abstract #
245
Poster Bd #
E24
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Quality Care Symposium
Are real-world patient-reported outcomes associated with survival in patients with advanced pancreatic cancer?
First Author: Wei Fang Dai
Poster
2011 ASCO Annual Meeting
The final analysis of a multicenter randomized controlled trial of gemcitabine (G) alone versus gemcitabine and S-1 combination therapy (GS) in patients with unresectable advanced pancreatic cancer (PC): GEMSAP study.
First Author: H. Isayama
Poster
2023 ASCO Gastrointestinal Cancers Symposium
First-line chemotherapy regimens associated with survival in advanced pancreatic cancer: A Mexican single-center, real-world study.
First Author: Marytere Herrera
Poster
2017 Gastrointestinal Cancers Symposium
Effect of advanced age, elevated bilirubin, and disease extent on outcomes of unresectable pancreatic cancer (UPC) patients receiving first-line chemotherapy: A population-based study.
First Author: Hannah Marie Cherniawsky